Haemonetics Corp (FRA:HAZ)
€ 68.5 0 (0%) Market Cap: 3.52 Bil Enterprise Value: 4.34 Bil PE Ratio: 33.39 PB Ratio: 4.21 GF Score: 73/100

Q1 2025 Haemonetics Corp Earnings Call Transcript

Aug 08, 2024 / 12:00PM GMT
Release Date Price: €77 (-1.28%)
Operator

Thank you for standing by, and welcome to Haemonetics Corporation's first quarter fiscal year 2025 earnings conference call. (Operator Instructions)

I would now like to hand the call over to Olga Guyette, Vice President, Investor Relations and Treasury. Please go ahead.

Olga Guyette
Haemonetics Corp - Vice President, Investor Relations and Treasury

Good morning, everyone. Thank you for joining us for Haemonetics' first quarter fiscal year 2025 conference call and webcast. I'm joined today by Chris Simon, our CEO; and James C. DâArecca, our CFO. This morning, we posted our first quarter fiscal year 2025 results to our Investor Relations website, along with our fiscal '25 guidance.

Before we begin, a quick reminder that all revenue growth rates discussed today are organic unless specified otherwise and exclude the impact of currency fluctuation and acquisitions.

Our organic revenue growth guidance for fiscal year 2025 incorporates 15 weeks of revenue from offsets due to the acquisition closing date being in December 2023. We'll also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot